
CAFC Rehears Teva and GSK Skinny Label Case
shot by IP News Shots / 7:02 pm on 24 February, 2021
The US Court of Appeals for the Federal Circuit (CAFC) is rehearing a case of patent infringement between GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd. In the previous hearing of the case, the CAFC had revived a $235 million win for GSK but was reheard due to an outrage on the fact that the ruling contradicted the Hatch-Waxman Act.
Read More at: https://www.law360.com/trials/articles/1353756/fed-circ-tailors-arguments-after-teva-skinny-label-outcry
Industry: Pharmaceuticals | Type of IP: Litigations